This company has been marked as potentially delisted and may not be actively trading. TradeUP Acquisition (UPTD) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock UPTD vs. CVM, OMGA, AIM, FRTX, APTO, ONVO, GENE, SQZ, SRNE, and KRBPShould you be buying TradeUP Acquisition stock or one of its competitors? The main competitors of TradeUP Acquisition include CEL-SCI (CVM), Omega Therapeutics (OMGA), AIM ImmunoTech (AIM), Fresh Tracks Therapeutics (FRTX), Aptose Biosciences (APTO), Organovo (ONVO), Genetic Technologies (GENE), SQZ Biotechnologies (SQZ), Sorrento Therapeutics (SRNE), and Kiromic BioPharma (KRBP). These companies are all part of the "biological products, except diagnostic" industry. TradeUP Acquisition vs. Its Competitors CEL-SCI Omega Therapeutics AIM ImmunoTech Fresh Tracks Therapeutics Aptose Biosciences Organovo Genetic Technologies SQZ Biotechnologies Sorrento Therapeutics Kiromic BioPharma CEL-SCI (NYSE:CVM) and TradeUP Acquisition (NASDAQ:UPTD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation. Which has stronger earnings & valuation, CVM or UPTD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCEL-SCIN/AN/A-$26.92M-$12.61-0.28TradeUP AcquisitionN/AN/A-$1MN/AN/A Which has more volatility & risk, CVM or UPTD? CEL-SCI has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500. Comparatively, TradeUP Acquisition has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Is CVM or UPTD more profitable? TradeUP Acquisition's return on equity of 0.00% beat CEL-SCI's return on equity.Company Net Margins Return on Equity Return on Assets CEL-SCIN/A -238.05% -104.65% TradeUP Acquisition N/A N/A -3.38% Does the media favor CVM or UPTD? In the previous week, CEL-SCI had 7 more articles in the media than TradeUP Acquisition. MarketBeat recorded 7 mentions for CEL-SCI and 0 mentions for TradeUP Acquisition. TradeUP Acquisition's average media sentiment score of 0.67 beat CEL-SCI's score of -0.52 indicating that TradeUP Acquisition is being referred to more favorably in the news media. Company Overall Sentiment CEL-SCI Negative TradeUP Acquisition Positive Do institutionals and insiders believe in CVM or UPTD? 12.1% of CEL-SCI shares are owned by institutional investors. Comparatively, 35.0% of TradeUP Acquisition shares are owned by institutional investors. 9.9% of CEL-SCI shares are owned by insiders. Comparatively, 55.1% of TradeUP Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryTradeUP Acquisition beats CEL-SCI on 6 of the 8 factors compared between the two stocks. Get TradeUP Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for UPTD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPTD vs. The Competition Export to ExcelMetricTradeUP AcquisitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.91M$215.80M$5.56B$9.11BDividend YieldN/AN/A5.07%4.01%P/E RatioN/AN/A21.2120.54Price / SalesN/A253.11432.0899.78Price / CashN/A22.4437.1257.67Price / Book-0.556.158.045.49Net Income-$1M-$96.61M$3.19B$250.45M TradeUP Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPTDTradeUP AcquisitionN/A$0.88-4.8%N/A-28.9%$1.91MN/A0.002,021Gap DownCVMCEL-SCI0.1779 of 5 stars$2.49-1.2%N/A-90.4%$7.55MN/A-5.1943News CoverageGap UpHigh Trading VolumeOMGAOmega Therapeutics2.032 of 5 stars$0.13-21.8%$8.50+6,700.0%-93.5%$6.92M$8.10M-0.09120Gap UpAIMAIM ImmunoTech1.1244 of 5 stars$8.85-3.5%$275.00+3,007.3%-74.4%$6.76M$146K-18.8320Gap UpFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+1.6%$5.59M$10.06M-0.6620APTOAptose Biosciences1.1659 of 5 starsN/A$6.00+∞N/A$3.66MN/A-0.5831Gap DownHigh Trading VolumeONVOOrganovoN/AN/AN/AN/A$3.47M$122K-2.4020Gap UpGENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeSQZSQZ BiotechnologiesN/A$0.03flatN/AN/A$826K$18.16M-0.011,620SRNESorrento Therapeutics0.3782 of 5 stars$0.00-7.1%N/A-78.2%$717K$60.32M0.00800High Trading VolumeKRBPKiromic BioPharmaN/AN/AN/AN/A$330KN/A-0.0660Gap DownHigh Trading Volume Related Companies and Tools Related Companies CEL-SCI Alternatives Omega Therapeutics Alternatives AIM ImmunoTech Alternatives Fresh Tracks Therapeutics Alternatives Aptose Biosciences Alternatives Organovo Alternatives Genetic Technologies Alternatives SQZ Biotechnologies Alternatives Sorrento Therapeutics Alternatives Kiromic BioPharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPTD) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TradeUP Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share TradeUP Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
